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Copyright © 2011 JCBN 2011 This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. Persistent oxidative stress has been associated with carcinogene 
sis. Iron overload is considered one such condition that causes oxi 
dative stress. Epidemiological studies support a close link
between iron overload and carcinogenesis. Reportedly, regular
semiannual phlebotomies reduced cancer risk in an otherwise nor 
mal population. More specifically, genetic hemochromatosis,
chronic viral hepatitis, ovarian endometriosis and asbestosis
induce iron overload, which can lead to hepatocellular carcinoma,
ovarian carcinoma or mesothelioma in humans. Through a combi 
nation of animal experiments and microarray analyses, homozy 
gous deletion of CDKN2A/2B has been recognized as one of the
major target genes involved in iron overload induced carcinogen 
esis.  CDKN2A/2B are the second most frequently inactivated
tumor suppressing genes in human cancers. Currently, when
infection is becoming sufficiently controlled worldwide, iron reg 
ulation may be the next target for human longevity.
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Introduction Most living species on earth, including humans, use oxygen.
Indeed, we cannot live without oxygen for even 5 min. Why
is oxygen so important? This is principally based on the chemical
characteristics of oxygen; a series of reductions by one electron
each is possible four times, until the oxygen is reduced to a stable
species and solvent, H2O (Fig. 1). This characteristic enables
efficient electron flow that is essential for any moving material,
including motors and robots. During this electron flow, three
intermediate species are generated, among which hydroxyl radical
(￿OH) has been identified as the most damaging to biomolecules.
Accordingly, cells strategically prevent the generation of ￿OH by
metabolizing H2O2 directly into H2O via various types of enzymes,
including catalase, peroxidases and peroxiredoxins. Even excess
O2￿− is metabolized to H2O2. The roles of O2￿− and H2O2 as
signaling molecules have been well established by studies within
the past two decades.(1) The adverse effects of oxygen were
already recognized in the 1950’s, and oxygen free radicals were
hypothesized to be the direct cause of aging.(2)
Cancer has been the leading cause of death in Japan for 30
years, while in most western countries, coronary heart disease is
the current leading cause of death. I suspect that cancer would
become the predominant cause of death in western countries as
well if metabolic syndrome could be overcome by proper preven-
tive exercise and diet. Currently, most of the fatal infections are
well controlled worldwide. The longer we live, the more genetic
alterations we obtain through persistent oxygen consumption and
environmental exposure to genotoxic agents.
Persistent oxidative stress has been associated with carcino-
genesis.(3) The causes of oxidative cellular stress stem mainly from
direct and indirect exogenous sources. Examples of direct causes
are X-radiation and ultraviolet radiation. Thus, exposure to atomic
bomb radiation in Hiroshima and Nagasaki was shown to increase
leukemia and lymphoma,(4) and ultraviolet radiation has been
closely associated with skin cancer.(5) Indirect sources of oxidative
stress include inflammation. Chronic Helicobacter pylori infection
is associated with gastric cancer and low-grade lymphoma of
mucosa-associated lymphoid tissue.(6,7)
Similarly, inflammatory bowel diseases such as Crohn’s dis-
ease(8) and ulcerative colitis(9) are associated with colon cancer.
In these cases, inflammation causes pain and various other
symptoms, and X-radiation is currently under strict legal regula-
tion. However, we should not forget iron overload as a cause of
oxidative stress. Iron overload per se does not induce inflam-
mation, nor is it under legal control. Although the pathology of
iron overload is really insidious, it can eventually lead to cancer.
In this sense, iron overload is really a quiet “time bomb”.
Iron and Carcinogenesis
Iron is ubiquitous, and no living organisms on earth can do
without iron. Iron deficiency causes anemia, but excess iron can be
a risk for carcinogenesis because iron works as a catalyst for the
Fenton reaction, thus promoting the generation of the undesirable
molecule,  ￿OH (Fig. 1). Iron stores within the body accumulate
insidiously with aging because iron intake exceeds loss and no
biologic mechanisms exist for excretion of iron in excess of
physiological requirements.(10) It was initially reported in 2008
that iron reduction by phlebotomy not only decreased visceral
cancer risk by 35% but also decreased mortality in cancer patients
by 60% in a supposedly normal population with peripheral arterial
disease.(11) In spite of some criticisms regarding design of this
study, this is a highly significant observation supporting other
epidemiological studies(12,13) and one should not underestimate the
role of iron in carcinogenesis.
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There are ample human epidemiological data to support the
involvement of excessive iron in carcinogenesis. Genetic hemo-
chromatosis is a hereditary disorder of iron sensing and currently
4 genetic types are recognized. Among them, autosomal recessive
HFE (OMIM +235200) is a major type.(14) A mutation in the gene
encoding SLC40A1 (OMIM #606069) is associated with an auto-
somal-dominant type of hemochromatosis. It is of note that defects
in HAMP (OMIM #602390) or in transferrin receptor 2 (OMIM
#604250) also induce hemochromatosis. Major causes of death
today in hereditary hemochromatosis are due to either hepatic
failure with cirrhosis or hepatocellular carcinoma.(15) In addition,
hemochromatosis patients were shown to have 240-fold greater
risk developing primary hepatocellular carcinoma than the age-
matched control population.(16)
Persistent damage to hepatocytes reduces the production of a
peptide hormone, hepcidin, leading to iron absorption and deposi-
tion irrespective of existing iron stores.(17) Thus, hepatic iron levels
are significantly increased in patients with chronic viral hepatitis
B/C. Currently, phlebotomy along with a low iron diet is the
second-line therapeutic strategy after α-interferon administration
to prevent hepatocellular carcinoma in Japan.(18)
Several epidemiological studies have suggested an association
between endometriosis and ovarian cancer by demonstrating a
high risk of ovarian cancer in women with a long-standing history
(>10 years) of ovarian endometriosis.(19) Here, hemorrhagic reten-
tion every month leads to localized iron overload in the ovary.
We recently showed that the epithelia of endometriotic cysts are
oxidatively stressed and contain high levels of catalytic iron.(20)
Asbestos fibers have been heavily used for industrial applica-
tions since World War II because of their durability, heat-
resistance and low cost. However, in 1987, IARC designated
asbestos fibers as a Group I (definite) carcinogen for humans
(http://monographs.iarc.fr/ENG/Classification/crthgr01.php). Epi-
demiological studies suggest that asbestos fibers that contain iron
(a transition metal which catalyzes free radical generation) are
more carcinogenic.(21)
Target Gene in Iron Induced Carcinogenesis
Our research group has been working on iron-induced carcino-
genesis for more than 20 years. I came across the ferric nitrilotri-
acetate (Fe-NTA)-induced renal carcinogenesis model when I
was a graduate student. Prof. Shigeru Okada, my mentor, seren-
dipitously discovered this model while he was studying the iron
loading effects of Fe-NTA on the liver.(22) Chelation of metals
alters their biological effects, presumably because metals are not
easily dissolved into solution at neutral pH while chelation makes
dissolution possible.(23) This is an excellent model that accurately
reproduces both acute renal tubular damage and carcinogenesis.(24)
Multiple studies and subsequent papers have been based on the
use of this single model, including the development of monoclonal
antibodies against 4-hydroxy-2-nonenal-modified proteins(25) and
8-hydroxy-2'-deoxyguanosine.(26)
Fe-NTA is an efficient catalyst for the Fenton reaction to generate
￿OH. Hydroxyl radical is one of the most reactive chemical species
in biology. Thus, it is natural to think that every portion of the
genome is randomly damaged by this species and to hypothesize
that there would be no specific target genes in this carcinogenesis
model. We tried to address this question in the 1990’s and un-
expectedly found that target genes do exist. At that time, rat
genomic information was largely not available, so we had to liter-
ally perform thousands of PCR reactions to find common allelic
loss in the genome by using microsatellite markers. Fortunately,
we reached a conclusion that CDKN2A/2B, which encode inhibitors
for cyclin-dependent kinases, are major target genes in this model.
Approximately one third of the cases had homozygous deletion of
these tumor suppressing genes.(27) Recently, our results were con-
firmed with a modern technology called array-based comparative
genome hybridization analysis.(28)
Surprisingly, CDKN2A/2B are target genes in human malignant
mesothelioma, a type of cancer which has been strongly associated
with asbestos exposure. Excessive iron is thought to be a principal
pathology.(29) As many as 74% of cases of human malignant meso-
thelioma had homozygous deletion of CDKN2A.(30) We observed
an even higher frequency of homozygous deletion of CDKN2A/2B
in rat peritoneal mesothelioma induced either by chryostile,
crocidolite or amosite (Jiang L and Toyokuni S, unpublished
observation). Interestingly, iron compounds alone (ferric saccharate
with nitrilotriacetate) can generate malignant mesothelioma in
rats albeit lower incidence and longer incubation period, and we
recently found that sarcomatoid types of these mesotheliomas had
a high incidence (80%) of homozygous deletion of CDKN2A.(31)
CDKN2A/2B as an Iron Overload Associated Gene
Based on these three examples of animal experiments, we can
hypothesize that excess iron causes deletion of CDKN2A/2B.
The genomic sequence at CDKN2A generates another tumor
suppressing gene called ARF by alternative splicing that works as
an inhibitor of TP53 specific ubiquitin ligase.(32) CDKN2B is a
backup for CDKN2A.(33) Thus, this genomic location acts as a
guardian of the genome, and genes corresponding to this location
are involved in both the RB and TP53 pathways (Fig. 2). It is also
interesting to note that P16 protein (the product of CDKN2A)
levels decrease with age,(34) and that established cancer cell lines
have a high incidence of CDKN2A homozygous deletion.(35) Taken
together, these findings suggest that oxidative stress, either by
excess iron or a high concentration of oxygen, induced this genetic
alteration.  CDKN2A/2B are really mysterious genomic points,
and we are currently using oxygenomics(36,37) as a strategy to
investigate the loci.
Conclusion and Strategy for Longevity
During this decade, iron metabolism has been further elucidated
and many novel molecules and transporters have been identified.(13)
Among the organelles, the mitochondrion is at the center of iron
metabolism, producing iron-sulfur cluster and heme. Abnormality
of its specific chaperone, frataxin, causes decreased iron storage in
mitochondria with concomitant cytoplasmic iron accumulation.
This can lead to a neurodegenerative disorder called Friedreich
ataxia,(38) thus indicating that iron excess damages neurons as well.
Throughout evolutional and developmental processes, iron
Fig. 2. Homozygous deletion of CDKN2A/2B and its biological signifi 
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has been and will continue to be necessary. However, it is now
apparent that iron excess is harmful and even promotes cancer.
This has important implications for human longevity. The current
mean lifetime for the Japanese was 86.1 years for females and 79.3
years for males in 2009. This is a great victory of the public health
service, considering that the mean lifetime expectancy was
approximately 50 years immediately following World War II. I
believe that it is time to consider the demerits of excess iron.
Iron modulation by phlebotomy (blood donation), low iron diet or
chelation therapy may be a strategy to prevent cancer and possibly
other diseases on the condition that the person is healthy and
without anemia (Fig. 3).
CDKN2A/2B are intriguing genomic crossroads for cancer
and aging, which is involved in both the RB and TP53 pathways.
This gene is evolutionally conserved between fish (Xyphophorus
maculates and Fugu rubripes) and mammals. Elucidation of the
evolution of this gene would help to clarify further grounds for
research into longevity.
Acknowledgments
This manuscript is dedicated to the first retirement of Prof.
Toshikazu Yoshikawa, who has been encouraging me for more
than 20 years to study in the field of free radical biology. This
work was supported in part by a MEXT grant (Special Coordina-
tion Funds for Promoting Science and Technology), a Grant from
Takeda Science Foundation, a Grant-in-Aid for Cancer Research
from the Ministry of Health, Labor and Welfare of Japan, and a
Grant-in-Aid from the Ministry of Education, Culture, Sports,
Science and Technology of Japan.
References
1 Woo HA, Yim SH, Shin DH, Kang D, Yu DY, Rhee SG. Inactivation of
peroxiredoxin I by phosphorylation allows localized H2O2 accumulation for
cell signaling. Cell 2010; 140: 517–528.
2 Harman D. Aging: a theory based on free radical and radiation chemistry. J
Gerontol 1956; 11: 298–300.
3 Toyokuni S. Molecular mechanisms of oxidative stress-induced carcino-
genesis: from epidemiology to oxygenomics. IUBMB Life 2008; 60: 441–447.
4 Preston D, Kusumi S, Tomonaga M, and et al. Cancer incidence in atomic
bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950–
1987. Radiat. Res 1994; 137: S68–S97.
5 Nishigori C, Hattori Y, Toyokuni S. Role of reactive oxygen species in skin
carcinogenesis. Antioxiol Redox Singnal 2004; 6: 561–570.
6 Uemura N, Okamoto S, Yamamoto S, and et al. Helicobacter pylori infection
and the development of gastric cancer. N Engl J Med 2001; 345: 784–789.
7 Naito Y, Yoshikawa T. Carcinogenesis and chemoprevention in gastric
cancer associated with Helicobacter pylori infection: role of oxidants and
antioxidants. J Clin Biochem Nutr 2005; 36: 37–49.
8 Ekbom A, Helmick C, Zack M, Adami H. Increased risk of large-bowel
cancer in Crohn’s disease with colonic involvement. Lancet 1990; 336: 357–
359.
9 Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcera-
tive colitis: a meta-analysis. Gut 2001; 48: 526–535.
10 Zacharski LR, Ornstein DL, Woloshin S, Schwartz LM. Association of age,
sex, and race with body iron stores in adults: analysis of NHANES III data.
Am Heart J 2000; 140: 98–104.
11 Zacharski LR, Chow BK, Howes PS, and et al. Decreased cancer risk after
iron reduction in patients with peripheral arterial disease: results from a
randomized trial. J Natl Cancer Inst 2008; 100: 996–1002.
12 Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free
Radic Biol Med 1996; 20: 553–566.
13 Toyokuni S. Role of iron in carcinogenesis: cancer as a ferrotoxic disease.
Cancer Sci 2009; 100: 9–16.
14 Lyon E, Frank EL. Hereditary hemochromatosis since discovery of the HFE
gene. Clin Chem 2001; 47: 1147–1156.
15 Milman N, Pedersen P, á Steig T, Byg KE, Graudal N, Fenger K. Clinically
overt hereditary hemochromatosis in Denmark 1948–1985: epidemiology,
factors of significance for long-term survival, and causes of death in 179
patients. Ann Hematol 2001; 80: 737–744.
16 Bradbear RA, Bain C, Siskind V, and et al. Cohort study of internal malig-
nancy in genetic hemochromatosis and other chronic nonalcoholic liver
diseases. J Natl Cancer Inst 1985; 75: 81–84.
17 Drakesmith H, Prentice A. Viral infection and iron metabolism. Nat Rev
Microbiol 2008; 6: 541–552.
18 Kato J, Miyanishi K, Kobune M, and et al. Long-term phlebotomy with low-
iron diet therapy lowers risk of development of hepatocellular carcinoma
from chronic hepatitis. Clin J Gastroenterol 2007; 42: 830–836.
19 Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A. Cancer risk after a
hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997;
176: 572–579.
20 Yamaguchi K, Mandai M, Toyokuni S, and et al. Contents of endometriotic
cysts, especially the high concentration of free iron, are a possible cause of
carcinogenesis in the cysts through the iron-induced persistent oxidative
stress. Clin Cancer Res 2008; 14: 32–40.
21 McDonald AD, McDonald JC, Pooley FO. Mineral fibre content of lung in
mesothelial tumours in North America. Ann Occup Hyg 1982; 26: 417–422.
22 Okada S, Midorikawa O. Induction of the rat renal adenocarcinoma by Fe-
nitrilotriacetate (Fe-NTA). Jpn Arch Intern Med 1982; 29: 485–491.
23 Toyokuni S, Okada S, Hamazaki S, Fujioka M, Li JL, Midorikawa
O. Cirrhosis of the liver induced by cupric nitrilotriacetate in Wistar rats. An
experimetnal model of copper toxicosis. Am J Pathol 1989; 134: 1263–1274.
24 Ebina Y, Okada S, Hamazaki S, Ogino F, Li JL, Midorikawa
O. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-
nitrilotriacetate complexes in rats. J Natl Cancer Inst 1986; 76: 107–113.
25 Toyokuni S, Miyake N, Hiai H, and et al. The monoclonal antibody specific
for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett 1995; 359: 189–191.
26 Toyokuni S, Tanaka T, Hattori Y, and et al. Quantitative immunohistochemical
determination of 8-hydroxy-2'-deoxyguanosine by a monoclonal antibody
N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis
model. Lab Invest 1997; 76: 365–374.
27 Tanaka T, Iwasa Y, Kondo S, Hiai H, Toyokuni S. High incidence of allelic
loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor
suppressor genes in oxystress-induced renal cell carcinoma of rats. Oncogene
1999; 18: 3793–3797.
28 Liu YT, Shang DG, Akatsuka S, and et al. Chronic oxidative stress causes
amplification and overexpresson of ptprz1 protein tyrosine phosphatase to
activate β-catenin pathway. Am J Pathol 2007; 171: 1978–1988.
29 Jiang L, Nagai H, Ohara H, and et al. Characteristics and modifying factors
of asbestos-induced oxidative DNA damage. Cancer Sci 2008; 99: 2142–
2151.
30 Illei PB, Rusch VW, Zakowski MF, Ladanyi M. Homozygous deletion of
CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in
the majority of pleural mesotheliomas. Clin Cancer Res 2003; 9: 2108–2113.
Fig. 3. Strategy for longevity from the standpoint of appropriate iron
stores for age. J. Clin. Biochem. Nutr. | January 2011 | vol. 48 | no. 1 | 49
©2011 JCBN
S. Toyokuni
31 Hu Q, Akatsuka S, Yamashita Y, and et al. Homozygous deletion of
CDKN2A/2B is a hallmark of iron-induced high-grade rat mesothelioma. Lab
Invest 2010; 90: 360–373.
32 Honda R, Yasuda H. Association of p19(ARF) with Mdm2 inhibits ubiquitin
ligase activity of Mdm2 for tumor suppressor p53. EMBO J 1999; 18: 22–27.
33 Krimpenfort P, Ijpenberg A, Song JY, and et al. p15(Ink4b) is a critical
tumour suppressor in the absence of p16(Ink4a). Nature 2007; 448: 943–946.
34 Campisi J. Senescent cells, tumor suppression, and organismal aging: good
citizens, bad neighbors. Cell 2005; 120: 513–522.
35 Herman JG, Merlo A, Mao L, and et al. Inactivation of the CDKN2/p16/
MTS1 gene is frequently associated with aberrant DNA methylation in all
common human cancers. Cancer Res 1995; 55: 4525–4530.
36 Akatsuka S, Aung TT, Dutta KK, and et al. Contrasting genome-wide distri-
bution of 8-hydroxyguanine and acrolein-modified adenine during oxidative
stress-induced renal carcinogenesis. Am J Pathol 2006; 169: 1328–1342.
37 Toyokuni S, Akatsuka S. What has been learned from the studies of oxidative
stress-induced carcinogenesis: proposal of the concept of oxygenomics. J
Clin Biochem Nutr 2006; 39: 3–10.
38 Cavadini P, O’Neill HA, Benada O, Isaya G. Assembly and iron-binding
properties of human frataxin, the protein deficient in Friedreich ataxia. Hum
Mol Genet 2002; 11: 217–227.